The pathophysiological link between PTX and improved survival is not clear but may include the reported effects of PTH on left ventricular hypertrophy, blood pressure control, erythropoietin-resistant anemia, nutritional status and humoral and/or cellular immunity, independently of calcium and phosphate control and of prescribed specific therapies [18–21]. The gene discussed is EPO; the disease is left ventricular hypertrophy.